We are live on
!
Find out more
MC
Merck & Co Portfolio holdings
AUM
$349M
1-Year Est. Return
146.07%
This Fund
S&P 500
1 Year Est. Return
+146.07%
AUM
$349M
AUM Growth
+$73.2M
(+26%)
Holding
14
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$23.9B
| $117M | 33.56% |
2,308,190
|
|
||
2
Personalis
PSNL
$1.07B
| $89.5M | 25.6% |
14,044,943
|
|
||
3
Kymera Therapeutics
KYMR
$8.22B
| $64.3M | 18.4% |
772,165
|
|
||
4
Entrada Therapeutics
TRDA
$272M
| $22M | 6.28% |
1,739,768
|
|
||
|
EIKN
5
Eikon Therapeutics
EIKN
$532M
| $17.6M | 5.05% |
+1,666,666
|
|
||
|
AKTS
6
Aktis Oncology
AKTS
$1.39B
| $17M | 4.88% |
+952,844
|
|
||
7
Alector
ALEC
$207M
| $7.62M | 2.18% |
3,545,719
|
|
||
8
Sutro Biopharma
STRO
$524M
| $6.78M | 1.94% |
272,351
|
|
||
|
EVAX
9
Evaxion A/S
EVAX
$28.6M
| $4.52M | 1.29% |
1,214,126
|
|
||
10
Viridian Therapeutics
VRDN
$1.95B
| $1.83M | 0.52% |
93,414
|
|
||
11
Xilio Therapeutics
XLO
$58.1M
| $891K | 0.26% |
105,982
-1
|
|
||
|
CARM
12
DELISTED
Carisma Therapeutics
CARM
| $47.9K | 0.01% |
1,473,240
|
|
||
|
NEUP
13
Neuphoria Therapeutics
NEUP
$23.9M
| $40.8K | 0.01% |
10,027
|
|
||
|
HURA
14
TuHURA Biosciences
HURA
$167M
| $34.8K | 0.01% |
19,445
+5,495
|
|